Purposes The Cks1 protein is a member of the highly conserved family of Cks/Suc1 proteins, which interact with Cdks, and was found to be an essential cofactor for efficient Skp2-dependent ubiquitination of p27. The present study was undertaken to examine the expression status of Cks1 in esophageal squamous cell carcinoma and its significance. Materials and Methods The expression of Cks1 in 140 esophageal squamous cell carcinoma patients was examined by immunohistochemistry. The correlations between Cks1 expression and tumor clinicopathologic features were analyzed. The effects of Cks1 expression on radiotherapy results were also examined. Results In the present study, we found that Cks1 is overexpressed in esophageal squamous cell carcinoma tissues. Elevated expression of Cks1 correlates significantly with tumor stage and positive lymph node metastasis (p < 0.05). Moreover, a significant negative correlation was found between Cks1 expression and the survival of patients who received radiotherapy (p < 0.05). At the molecular level, forced expression of Cks1 promotes the radio-resistance ability of EC9706 cells. Knockdown of Cks1 expression sensitizes cancer cells to radiation, and a wobble mutant of Cks1 that is resistant to Cks1 siRNA can rescue this effect. Conclusions These results demonstrate for the first time that overexpression of Cks1 correlates with the increased radiotherapy resistance of esophageal squamous cell carcinoma.
INTRODUCTION
Esophageal cancer is one of the most frequently occurring malignancies and the seventh leading cause of cancerrelated deaths in the world. Esophageal squamous cell carcinoma (ESCC) is the most prevalent type of esophageal cancer in China, and the survival rate of ESCC patients is less than 10%. 1, 2) The prognosis for patients with locally advanced esophageal cancer treated with the standard approaches of surgery or radiotherapy is poor. Treatment failure is mainly due to both a high incidence of localregional failure and early systemic dissemination of the disease, 3, 4) making radio-sensitization a promising approach to improve the therapeutic ratio for irradiation.
Cks1 is required for SCF
Skp2
-mediated ubiquitination and degradation of p27 kip1 , which is essential for the G1/S transition during the cell cycle. 5, 6) Some studies have investigated the expression of Cks1 in different human cancers and its relation to Skp2 and p27 expression. 7, 8) Our previous study showed that Cks1 is amplified and overexpressed in breast cancer. Its amplification and overexpression were strongly associated with lymph node metastasis and poor prognosis. 9) Until now, there were no reports indicating that Cks1 has an effect on the radiotherapy for ESCC. In the present study, we found for the first time that Cks1 expression correlates with the prognosis of ESCC patients who received radiotherapy. Increased Cks1 levels improve the radiation resistance ability of ESCC cells.
MATERIALS AND METHODS

Tissue specimens
One hundred forty fresh tissues containing esophageal squamous cell carcinomas and adjacent histologically 
Immunohistochemical staining
A total of 140 formalin-fixed, paraffin-embedded esophageal squamous cell carcinomas and the corresponding normal epithelium were collected for immunohistochemical analysis. The slides were deparafinized, rehydrated, and then immersed in 3% hydrogen peroxide solution for 10 min, heated in EDTA buffer, pH 8.0, at 95°C for 25 min, and cooled at room temperature for 60 min. The slides were blocked with 10% normal goat serum at 37°C for 30 min, and then incubated with rabbit polyclonal antibody against Cks1 (1:200, Santa Cruz) overnight at 37°C. The slides were washed with PBS, and then incubated with biotinylated second antibody (diluted 1:100) for 30 min at 37°C, followed by streptavidin-peroxidase (1:100 dilution) incubation at 37°C for 30 min. Immunolabeling was visualized with a mixture of DAB solution. Counterstaining was carried out with hematoxylin. The immunohistochemical slides were scored according to the percentage of tumor cells exhibiting nuclear staining. The extent of Cks1-positive staining in the nuclei was scored into three grades: 0 for < 10%, 1 for 10-30%, 2 for > 30%.
Plasmid construction and small interfering RNA synthesis
A synthetic double-stranded oligonucleotide with the following sequence was introduced into the pSilencer 3.1-H1 neo small interfering RNA (siRNA) expression vector (Ambion, Austin, TX):5'-GGGACATAGCCAAGCTGGTCgagtactgGACCAGCTTGGCTATGTCCC-3'. We used a circular control plasmid, which contains a scrambled sequence that does not show significant homology to rat, mouse, or human gene sequences, as a control. Mutant pcDNA3.1-Cks1 preserving the same amino acid sequence, but containing three point mutations in the target nucleotide sequence and therefore resistant to Cks1-RNAi, was produced by GeneChem (Shanghai, China).The wild-type Cks1 was cloned into pcDNA3.1 to create the overexpression vector.
Cell culture and transfection
The esophageal squamous cell carcinoma EC9706 cells were cultured in RPMI 1640 (Invitrogen) supplemented with 10% FBS. Cell transfections were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instruction. For transient transfections, 100 nM Cks1 siRNA or scrambled siRNA were used, and cells were harvested 48 h after transfections. In the stable transfection, cells were selected with 200 μg/ml G418, and clones were isolated by serial dilution. The pool of Cks1 overexpression and Cks1 RNAi clones were chosen for subsequent experiments.
Western blot analysis
Whole cell extracts were prepared from ESCC tissues and 
Colony formation assay
Four hundred cells were aliquoted into each well of a 6-well plate in triplicate and exposed to γ rays with a dose of 5 Gy. After 10 days of incubation, the colonies were stained with Giemsa stain, and a minimum of 50 viable cells were counted. Quantity One software (version 4.6.
2) was used to analyze the results.
Flow cytometry
Cells were harvested 8 hours post irradiation with a dose of 5 Gy for apoptosis detection using the annexin V-FITC apoptosis detection kit (Sigma) and subsequently analyzed by flow cytometry.
Statistical analysis
All statistical analyses were performed using SPSS16.0 software. We statistically evaluated experimental results using the Kruskal-Wallis test, Mann-Whitney test and Fig. 1 . Representative Cks1 immunostaining in an esophageal carcinoma and normal epithelium of the same case. Low expression of Cks1 was detected in normal esophageal epithelium. Esophageal squamous carcinoma cells were strongly stained. ANOVA test. Survival curves were constructed using the Kaplan-Meier method. p < 0.05 was considered statistically significant. (Fig. 1) . Statistical analysis indicated that elevated expression of Cks1 was significantly associated with tumor stage, clinical stage and positive lymph node metastasis (p < 0.05) ( Table 2) .
RESULTS
Overexpression of Cks1 in esophageal squamous cell carcinoma
Next, we analyzed the effects of Cks1 expression on patient's survival. No association was found between Cks1 expression and overall survival (p = 0.507) ( Fig. 2A) . But in the patients that received concurrent chemotherapy with radiation therapy (98 out of 140), the survival rate of patients with low Cks1 expression was significantly higher than that of patients with high Cks1 expression (p = 0.001) (Fig. 2B) . In contrast, in the patients who did not receive radiotherapy (42 out of 140), no difference was found between Cks1 high expression and low expression (p = 0.204) (Fig. 2C) . In order to further confirm whether Cks1 expression has effects on the prognosis of ESCC patients who received concurrent chemotherapy with radiation therapy, a multivariate analysis was performed to evaluate the independent prognostic roles of lymph node metastasis, tumor stage and Cks1 expression. Results showed that Cks1 expression (p = 0.039), regional lymph node metastasis (p = 0.006) and tumor stage (p = 0.021) were independent prognostic factors, respectively (Table 2 ).These results showed that Cks1 expression status may have effects on the radiotherapy outcome of ESCC patients.
Effects of Cks1 on the radio-sensitivity of EC9706 cells
To confirm the clinical data, we examined the Cks1 expression in EC9706 cells at 0, 2, 4, 8 and 12 hours after radiation with a dose of 5 Gy. Cks1 expression was increased after radiation. Its level was highest at 8 hours and decreased at 12 hours, showing that Cks1 may have effects on the radiation response of EC9706 cells (Fig. 3) .
A colony formation assay was performed to examine the effects of Cks1 expression on the radio-sensitivity of EC9706 cells. The survival fraction of Cks1 knock-down cells was significantly lower than that of control groups ( Fig. 4A and B) . Conversely, the survival fraction of cells with forced Cks1 expression was higher than that of control groups ( Fig. 4C and D) . These results indicated a correlation Fig. 3 . Expression of Cks1 induced by radiation in EC9706 cells. Elevated Cks1 was observed after γ ray radiation with a dose of 5 Gy, and its level was highest at 8 hours.
between Cks1 expression and radio-sensitivity of EC9706 cells to gamma radiation. We also repeated colony formation assay in another kind of ESCC cell, KYSE150 cell line, the result was accordance with previous (Supplemental Fig. 1 ).
Effects of Cks1 on the apoptosis of EC9706 cells induced by gamma radiation
We examined the effects of Cks1 expression on cell apoptosis induced by gamma radiation with a dose of 5 Gy. Compared with parental and vector groups, the percentage of apoptotic cells in the high Cks1 expression group was significantly decreased (p < 0.01) (Fig. 5) . Conversely, the percentage of apoptotic cells in the Cks1 knockdown group was significantly higher than that of the control group (p < 0.01) (Fig. 6A and B) .
To verify that the effects of RNAi described above are specific, we prepared a Cks1 construct bearing triple-point mutation in the 16-bp sequence that served as target for shRNA-mediated knockdown in our experiments. The mutation conserved the amino acid sequence of the Cks1 protein but rendered its expression insensitive to inhibition by the shRNA. Transfection of this mutant shRNA into the cells with stable expression of Cks1-shRNA indeed restored the ability of Cks1 to promote the radio-resistance of EC9706 cells (Fig. 6C and D) . These results were further confirmed in KYSE 150 cell line (Supplemental Fig. 1) . 
DISCUSSION
Overexpression of Cks1 has been observed in various types of human tumors, and elevated expression of Cks1 indicated poor prognoses for patients with gastric carcinoma, 10) oral squamous cell carcinoma, non-small cell lung cancer 11) and prostate cancer. 12) Masuda et al. found that Cks1 overexpression was correlated with poor prognosis and reduced expression of p27 in gastric carcinoma. 10) Our previous studies have revealed that Cks1 is amplified and overexpressed in breast cancer. Its overexpression correlated significantly with tumor stage and positive lymph node metastasis. 9) But there have been no reports on Cks1 expression in ESCC until now, so we used immunohistochemistry to examine the expression of Cks1 in ESCC. Our results showed for the first time that Cks1 expression increased in ESCC. Its expression was significantly correlated with tumor stage and positive lymph node metastasis. Some studies have reported that increased Cks1 expression was associated with poor prognosis in colorectal carcinoma and breast cancer. 13) However, no correlation was found between Cks1 expression and over survival of ESCC patients in the present study. Because some patients in our study received radiotherapy treatment and others did not and the chemotherapy treatment was identical for each of these 140 patients, we inquired as to whether Cks1 expression affects radiotherapy outcome. Survival analysis showed that only the overall survival time of patients received concurrent chemotherapy with radiation therapy was affected by Cks1 expression. Given the strong correlation of Cks1 overexpression with T-stage and lymph nodes metastasis, both of them have been known as most important prognostic factors in all malignancies, so multivariate Cox analysis was performed to confirm this data. Results showed that Cks1 was an independent prognostic factor for the survival of patients who received concurrent chemotherapy with radiation therapy. These results were further confirmed in two kinds of ESCC cell lines, EC9706 and KYSE150. This was the first report about the correlation between Cks1 expression and radiation resistant of carcinoma. It has been found that overexpression of Cks1 or Cks2 in human mammary epithelial lead to over- ride of the intra-S-phase checkpoint that blocks DNA replication in response to replication stress. Binding of Cks1 or Cks2 to cyclin-dependent kinase 2 confers partial resistance to the effects of inhibitory tyrosine phosphorylation mediated by the intra-S-phase checkpoint, allowing cells to continue replicating DNA even under conditions of replicative stress. 14) Radiation is just one of the replicative stresses, so Cks1 may promote radiation resistant of ESCC cells through increasing DNA replication ability.
Lan et al. reported that knockdown of Cks1 expression in malignant prostate tumor cells inhibited proliferation, anchorage-independent growth and migration activities, whereas knockdown of Cks2 expression induced programmed cell death.
12) Decreased Cks1 induced G2/M phase arrest and apoptosis in human lung cancer cells. 15) Our previous study also found that overexpression of Cks1 inhibited the apoptosis of breast cancer cells through the MEK-Erk pathway. 9) However, no reports have described the effects of Cks1 expression on cell apoptosis induced by radiation. In the present study, we found that overexpression of Cks1 promoted the apoptosis of EC9706 cells induced by radiation. Whether this effect was also accomplished through the MEK-Erk pathway should be further explored.
In conclusion, we found for the first time that Cks1 expression correlates with the prognosis of ESCC patients who receive radiotherapy. Increased Cks1 promoted the radiation resistance ability of ESCC cells.
